Scinai Immunotherapeutics Ltd. Quarterly Common Stock, Shares, Outstanding from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Scinai Immunotherapeutics Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2021 to Q2 2024.
  • Scinai Immunotherapeutics Ltd. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 3.35B shares, a 130% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.35B +1.9B +130% Jun 30, 2024 6-K 2024-09-09
Q4 2023 1.86B +868M +87.7% Dec 31, 2023 6-K 2024-09-09
Q2 2023 1.45B Jun 30, 2023 6-K/A 2023-08-18
Q1 2023 1.31B Mar 31, 2023 10-Q 2023-05-15
Q4 2022 989M +250M +33.9% Dec 31, 2022 20-F 2024-05-15
Q4 2021 739M Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.